Dr. Reddy's Laboratories Limited (BOM:500124)
1,197.75
-4.40 (-0.37%)
At close: Oct 31, 2025
Dr. Reddy's Laboratories Revenue
Dr. Reddy's Laboratories had revenue of 88.05B INR in the quarter ending September 30, 2025, with 9.84% growth. This brings the company's revenue in the last twelve months to 342.15B, up 14.10% year-over-year. In the fiscal year ending March 31, 2025, Dr. Reddy's Laboratories had annual revenue of 325.54B with 16.61% growth.
Revenue (ttm)
342.15B
Revenue Growth
+14.10%
P/S Ratio
2.91
Revenue / Employee
12.30M
Employees
27,811
Market Cap
997.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 325.54B | 46.37B | 16.61% |
| Mar 31, 2024 | 279.16B | 33.29B | 13.54% |
| Mar 31, 2023 | 245.88B | 31.49B | 14.69% |
| Mar 31, 2022 | 214.39B | 24.67B | 13.00% |
| Mar 31, 2021 | 189.72B | 15.12B | 8.66% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 10.00T |
| Life Insurance Corporation of India | 9.04T |
| State Bank of India | 3.50T |
| Larsen & Toubro | 2.76T |
| HDFC Bank | 2.68T |
| Tata Consultancy Services | 2.58T |
| ICICI Bank | 1.91T |
| Bharti Airtel | 1.84T |
Dr. Reddy's Laboratories News
- 2 days ago - Dr. Reddy's Laboratories Becomes Oversold (RDY) - Nasdaq
- 4 days ago - Dr. Reddy’s Laboratories shares fall over 4% after delay in Semaglutide approval in Canada - Business Upturn
- 4 days ago - Dr. Reddy's: Underappreciated Future Amid Exaggerated Headwinds - Seeking Alpha
- 4 days ago - RDY Crosses Below Key Moving Average Level - Nasdaq
- 4 days ago - Nifty 50 top losers today, October 29: Dr. Reddy’s Laboratories, Coal India, Bharat Electronics, Eternal and more - Business Upturn
- 6 days ago - Why Indian pharma giant Dr Reddy's is unfazed by Trump's tariff threats - CNBC
- 6 days ago - Dr Reddy's Laboratories Ltd (RDY) (Q2 FY26) Earnings Call Highlights: Navigating Growth Amidst ... - GuruFocus
- 6 days ago - Half Year 2026 Dr Reddy's Laboratories Ltd Earnings Call Transcript - GuruFocus